Real Estate
AI Score 71/100

Swiss Medtech Company with Globally Patented 3D Bioprinting Technology Seeks Successor

SwitzerlandFounded 2000

Annual revenue
Not disclosed
EBITDA margin
Not disclosed
Employees
1 – 5
Asking price
Sign in to view

About this business

This Swiss medtech company with a patented 3D bioprinting technology has solid fundamentals but lacks some key details. The niche technology has high potential, but the limited financial and geographic data make it a moderate-risk acquisition target. Score: 71/100 — Industry: 19/25, Pricing: 15/25, Geography: 10/20, Urgency: 12/15, Quality: 15/15 --- Cette entreprise suisse de medtech avec une technologie de bioimpression 3D brevetée a des bases solides mais manque de certains détails clés. La technologie de niche a un fort potentiel, mais les données financières et géographiques limitées en font une cible d'acquisition à risque modéré.

Full description available after signup.

What you'll see after signing the NDA

  • → Exact revenue, EBITDA, and asking price
  • → Full business description and operational details
  • → Seller contact information
  • → Customer concentration and key revenue sources
  • → Reason for sale and ideal buyer profile
  • → Direct introduction to the seller

Confidential. Legally binding under Swiss law. Free.

Similar businesses for sale